# Nuclide record idea-dosimetry-guided-dosing-standard (idea). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/ideas/idea-dosimetry-guided-dosing-standard/>
  a schema:CreativeWork ;
  nuclide:kind "idea" ;
  schema:identifier "idea-dosimetry-guided-dosing-standard" ;
  schema:name "Kidney-dosimetry-guided dosing as the default for PSMA radioligand therapy"@en ;
  schema:description "Right now, most patients get the same number of treatment cycles at the same radioactive dose regardless of their own biology. Measuring how much radiation actually reaches each patient's kidneys after the first dose could let doctors safely give some patients more cycles and stop earlier in others, rather than using one fixed schedule for everyone."@en ;
  schema:url <https://nuclide.cc/ideas/idea-dosimetry-guided-dosing-standard/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06216249>, <https://clinicaltrials.gov/study/NCT06943495>, <https://www.hmpgloballearningnetwork.com/site/rpei/conference-coverage/personalized-dosimetry-guides-177lu-psma-617-therapy-prostate-cancer>, <https://link.springer.com/article/10.1007/s40336-026-00769-5>, <https://clinicaltrials.gov/study/NCT03511664> ;
  nuclide:tag "dosimetry", "personalised dosing", "prostate" ;
  nuclide:related <https://nuclide.cc/ideas/idea-net-dosimetry-prrt/>, <https://nuclide.cc/technologies/radioligand-dosimetry/>, <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/trials/vision/>, <https://nuclide.cc/isotopes/lu-177/> .